Membrane Lipid Remodeling Regulates Exosome Biogenesis and Function in Cancer

Tumor cells remodel their membrane lipids, and the extracellular vesicles (EVs) they release carry the result: EV lipid profiles differ from those of the parent cells because certain membrane components are selectively enriched. Headgroup chemistry, acyl-chain composition and cholesterol set how tightly a membrane packs and how easily it bends, and local anionic lipids recruit trafficking proteins. Two routes link these properties to exosome biogenesis: ARF6–PLD2–syntenin–ALIX, and ceramide production by neutral sphingomyelinase 2. Once vesicles are released, their surface lipids affect clearance and immune recognition. Phosphatidylserine promotes macrophage uptake and can suppress T cells, and vesicle-bound autotaxin delivers lysophosphatidic acid to receptors on recipient cells. In tumors these activities have been linked to angiogenesis and immune suppression, and in some settings to antitumor immunity. We review how lipid classes act in these processes, keeping changes in vesicle production apart from changes in cargo and signaling, and we outline the measurements needed to tie a lipid perturbation to an EV-mediated tumor phenotype. Therapeutic options that follow from this work include targeting phosphatidylserine-dependent recognition and lipid-mediated immune activation. EV lipid profiles are being explored as biomarkers, but their clinical value depends on the biofluid, the separation method and the intended diagnostic use.

Authors

Publication Details

Journal
Preprints.org
Published
2026-11-17
DOI
https://doi.org/10.20944/preprints202611.1641.v1
Primary Topic
Extracellular vesicles in disease
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Membrane Lipid Remodeling Regulates Exosome Biogenesis and Function in Cancer

Jingru Zhang, Yiyu Chen
1 links
Preprints.org
Extracellular vesicles in disease
preprint

Membrane Lipid Remodeling Regulates Exosome Biogenesis and Function in Cancer

Jingru Zhang, Yiyu Chen
preprint en

Abstract

Tumor cells remodel their membrane lipids, and the extracellular vesicles (EVs) they release carry the result: EV lipid profiles differ from those of the parent cells because certain membrane components are selectively enriched. Headgroup chemistry, acyl-chain composition and cholesterol set how tightly a membrane packs and how easily it bends, and local anionic lipids recruit trafficking proteins. Two routes link these properties to exosome biogenesis: ARF6–PLD2–syntenin–ALIX, and ceramide production by neutral sphingomyelinase 2. Once vesicles are released, their surface lipids affect clearance and immune recognition. Phosphatidylserine promotes macrophage uptake and can suppress T cells, and vesicle-bound autotaxin delivers lysophosphatidic acid to receptors on recipient cells. In tumors these activities have been linked to angiogenesis and immune suppression, and in some settings to antitumor immunity. We review how lipid classes act in these processes, keeping changes in vesicle production apart from changes in cargo and signaling, and we outline the measurements needed to tie a lipid perturbation to an EV-mediated tumor phenotype. Therapeutic options that follow from this work include targeting phosphatidylserine-dependent recognition and lipid-mediated immune activation. EV lipid profiles are being explored as biomarkers, but their clinical value depends on the biofluid, the separation method and the intended diagnostic use.

Preprints.org
Good health and well-being
Extracellular vesicles in disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon